Related Experiment Video
Updated: Sep 2, 2025

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Bivalent binding of p14ARF to MDM2 RING and acidic domains inhibits E3 ligase function
Dominika Kowalczyk1, Mark A Nakasone1, Brian O Smith2
1Cancer Research UK Beatson Institute, Glasgow, UK.
Abstract:
ARF tumor suppressor protein is a key regulator of the MDM2-p53 signaling axis. ARF interferes with MDM2-mediated ubiquitination and degradation of p53 by sequestering MDM2 in the nucleolus and preventing MDM2-p53 interaction and nuclear export of p53. Moreover, ARF also directly inhibits MDM2 ubiquitin ligase (E3) activity, but the mechanism remains elusive. Here, we apply nuclear magnetic resonance and biochemical analyses to uncover the mechanism of ARF-mediated inhibition of MDM2 E3 activity. We show that MDM2 acidic and zinc finger domains (AD-ZnF) form a weak intramolecular interaction with the RING domain, where the binding site overlaps with the E2∼ubiquitin binding surface and thereby partially reduces MDM2 E3 activity. Binding of human N-terminal 32 residues of p14ARF to the acidic domain of MDM2 strengthens the AD-ZnF-RING domain interaction. Furthermore, the N-terminal RxFxV motifs of p14ARF participate directly in the MDM2 RING domain interaction. This bivalent binding mode of p14ARF to MDM2 acidic and RING domains restricts E2∼ubiquitin recruitment and massively hinders MDM2 E3 activity. These findings elucidate the mechanism by which ARF inhibits MDM2 E3 activity.
Insights
The ARF tumor suppressor protein inhibits MDM2 E3 ligase activity by binding to both the acidic and RING domains of MDM2. This dual binding mechanism blocks E2∼ubiquitin recruitment, revealing how ARF regulates the MDM2-p53 pathway.
Area of Science:
- Molecular Biology
- Biochemistry
- Cancer Research
Background:
- ARF (alternative reading frame) is a crucial tumor suppressor.
- It regulates the MDM2-p53 signaling axis, impacting cell growth and survival.
- ARF inhibits MDM2's ubiquitin ligase activity, but the precise mechanism was unclear.
Purpose of the Study:
- To elucidate the molecular mechanism of ARF-mediated inhibition of MDM2 ubiquitin ligase (E3) activity.
- To investigate the structural basis of ARF-MDM2 interaction and its effect on E3 function.
Main Methods:
- Nuclear magnetic resonance (NMR) spectroscopy.
- Biochemical assays to analyze protein interactions and enzyme activity.
Main Results:
- MDM2's acidic and zinc finger domains (AD-ZnF) weakly interact with its RING domain, partially inhibiting E3 activity.
- p14ARF binding to MDM2's acidic domain enhances the AD-ZnF-RING interaction.
- p14ARF's RxFxV motifs directly engage the MDM2 RING domain, creating a bivalent interaction.
- This bivalent binding obstructs E2∼ubiquitin binding, significantly hindering MDM2 E3 activity.
Conclusions:
- ARF inhibits MDM2 E3 activity through a bivalent binding mechanism involving both MDM2 acidic and RING domains.
- This detailed mechanism clarifies how ARF functions as a tumor suppressor by modulating p53 stability.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Anaphase Promoting Complex
Master Transcription Regulators

